The Patch allows physicians to treat tattoos more efficiently by enabling rapid multiple laser passes in a single treatment session.
The Food and Drug Administration (FDA) initially granted clearance in April 2015 for use with the 755nm QS Alexandrite laser, which effectively removes blue- or black ink tattoos. The expanded approval now includes the use of 532nm, 694nm, 755nm, and 1064nm standard Q-Switched (QS) lasers, as well as the 532nm, 755nm, 785nm, and 1064nm standard picosecond lasers in Fitzpatrick Skin Type I–III patients. This allows for the ability to remove tattoos for a spectrum of colors.
The FDA clearance also includes an extended shelf life of the Patch from 2 years to 3 years.
The single-use Patch is a perfluorodecalin-infused gel-based skin barrier and optical clearing device used for laser-assisted tattoo removal procedures. The dual-layer silicone patch is placed over tattoos before laser removal and allows physicians to treat tattoos more efficiently through rapid multiple laser passes in a single session. At the correct wavelength, the Patch can be used to help remove colored tattoos.